Titanium dioxide nanoparticles (TiO 2 NPs) are used in paints, plastics, papers, inks, foods, toothpaste, pharmaceuticals and cosmetics. However, TiO 2 NPs cause inflammation, pulmonary damage, fibrosis and lung tumours in animals and are possibly carcinogenic to humans. Although there are a large number of studies on the toxicities of TiO 2 NPs, the data are inconclusive and the mechanisms underlying the toxicity are not clear. In this study, we used the Comet assay to evaluate genotoxicity and whole-genome microarray technology to analyse gene expression pattern in vivo to explore the possible mechanisms for toxicity and genotoxicity of TiO 2 NPs. Mice were treated with three daily i.p. injections of 50 mg/kg 10 nm anatase TiO 2 NPs and sacrificed 4 h after the last treatment. The livers and lungs were then isolated for the Comet assay and whole genome microarray analysis of gene expression. The NPs were heavily accumulated in liver and lung tissues. However, the treatment was positive for DNA strand breaks only in liver measured with the standard Comet assay, but positive for oxidative DNA adducts in both liver and lung as determined with the enzyme-modified Comet assay. The genotoxicity results suggest that DNA damage mainly resulted from oxidised nucleotides. Gene expression profiles and functional analyses revealed that exposure to TiO 2 NPs triggered distinct gene expression patterns in both liver and lung tissues. The gene expression results suggest that TiO 2 NPs impair DNA and cells by interrupting metabolic homeostasis in liver and by inducing oxidative stress, inflammatory responses and apoptosis in lung. These findings have broad implications when evaluating the safety of TiO 2 NPs used in numerous consumer products.
Introduction
As the ninth most abundant element in the world, 95% of titanium is present as titanium dioxide (TiO 2 ). TiO 2 is a highly insoluble, thermally stable, non-flammable and odourless. TiO 2 exists in several crystalline structures, mainly anatase, rutile and brookite (1) . TiO 2 is known for its optical and electrical properties along with other important features such as excellent resistance to chemical and UV degradation (2) . With these versatile features, TiO 2 has been used in various products, such as paint pigments, sunscreen lotions, electrochemical electrodes, capacitors, solar cells and also as a food colouring agent and an ingredient in toothpastes (3) .
Generally, TiO 2 at micro-scale dimensions has been defined as biologically inactive and physiologically inert in both human and animals under non-overload conditions (4) (5) (6) . TiO 2 nanoparticles (TiO 2 NPs, <100 nm) have increasingly been used in consumer products due to their unique properties derived from their small sizes. When sized down to nanoscale, the physical properties of TiO 2 NPs are different. TiO 2 NPs are transparent and able to absorb and reflect UV light. They also have large surface-area-to-weight ratios (7) and a high redox activity (8) , which increases their potential to cause adverse effects or intrinsic toxicity to human health (9) .
Nanoscale TiO 2 elicited a significant increase in induction of emphysema-like lung injury when compared to micro-scale TiO 2 in exposed mice (10) . Considering inhalation as the most likely route for TiO 2 NPs exposure in humans, many studies have focused on their pulmonary toxicological effects. Following treatment in various types of lung cells, TiO 2 NPs induced cytotoxicity (11) (12) (13) (14) (15) (16) , release of interleukin-8 (IL-8) (11) and radical oxygen species (ROS) (11, 14, (16) (17) (18) (19) . Similar potent adverse effects of anatase TiO 2 NPs also were found in animals as evidenced by increases of bronchoalveolar lavage (BAL) inflammatory parameters (20) (21) (22) (23) , lung tissue structural damage and inflammatory infiltration (9, 20, 24) . TiO 2 NPs have been classified by the International Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B carcinogen) based on sufficient evidence in experimental animals and inadequate evidence from epidemiology studies (25) . In addition, the National Institute for Occupational Safety and Health (NIOSH) has classified TiO 2 NPs as a potential occupational carcinogen (26) .
Besides damage to lung tissues, TiO 2 NP exposures also resulted in liver dysfunction. For example activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were enhanced in mouse livers following treatment with TiO 2 NPs (125 and 250 mg/ kg BW) by an intragastric administration every other day for 30 days (27) and also for the treatment with TiO 2 NPs at dose level of 50, 100 and 150 mg/kg BW in 14 day-treatment study via i.p, route (28) . Inflammatory responses, oxidative stress and hepatocyte apoptosis were also found in mouse livers treated with TiO 2 NPs (28-32). When TiO 2 NPs was given for 14 days via i.p. administration, inflammatory responses and hepatocyte apoptosis were found in mouse livers at dose level of 5, 10, 50, 100 and 500 mg/kg BW (29) and oxidative stress were found in mouse livers treated at dose level of 50, 100 and 500 mg/kg BW (30) . Inflammatory responses, oxidative stress and hepatocyte apoptosis were also noted in mouse livers when TiO 2 NPs (10 and 50 mg/kg BW) suspensions were given to mice by an intragastric administration every other day for 60 days (31, 32) .
Although there have been many studies showing the toxic effects of TiO 2 NPs in vitro, only a few studies have been published on the in vivo genotoxicity of TiO 2 NPs in the liver and lung of rodents. No consensus on TiO 2 NPs toxicity has been reached, and the underlying cellular and molecular mechanisms of TiO 2 NP toxicity are not yet fully understood. In this study, we conducted the Comet assay and gene expression analysis in the livers and lungs of mice treated with TiO 2 NPs to assess TiO 2 NP genotoxicity in their toxicological target tissues, and to understand the effects within the genome at the molecular levels.
Materials and methods

Characterisation of TiO 2 NPs
TiO 2 NPs used in the study was 10 nm anatase NPs, which we have previously characterised (33) . Briefly, the 10 nm anatase TiO 2 NPs powders were characterised for size distribution using a JEOL JEM 2100F transmission electron microscope (TEM) and a JEOL 7000F scanning electron microscope (SEM) and for chemical composition using energy dispersive spectroscopy (EDS) analysis. TiO 2 NPs (2.5 mg/ml) in PBS were prepared. The formulation was extensively sonicated immediately prior to analysis using the Malvern Zetasizer. The 10 nm uncoated anatase TiO2 NPs had a primary size approximately of 8.9-15.3 nm and the size distribution of the agglomerates in the PBS was found to be around 130 nm.
Animal treatment and tissues collection
All animal treatment procedures were conducted according to the requirement of the NCTR Animal Care and Use Committee. Male B6C3F1 mice from the NCTR breeding colony were used in this study. Mice were housed in conventional animal rooms with 2-3 animals per cage and were identified by ear clipping. Water and food were available ad libitum throughout the acclimation and experimental period. Each experimental condition group consisted of five 6-to 7-week-old male mice, which taken from two different cages, with body weight range of 25-33 g. The 10 nm TiO 2 NPs (powder) were suspended in PBS to achieve the required stock concentration. Colloidal suspensions of the TiO 2 NPs were obtained with vigorous mixing at 3000 rpm for 1 min and sonication using water sonicator Branson 2510 with output as 100 W and frequency as 40 kHz for 1 min before dosing. PBS was used as the vehicle control. Mice were given a repeated dose of 0 and 50 mg/kg/day for 3 days in this study via intraperitoneal injection (i.p.) at a dose volume of 20 ml/kg body weight for each animal. Since i.p. administration has frequently used for evaluation of chemical toxicity in liver and lung, we chose this route to treat animal (34) (35) (36) (37) . Also, since doses over 50 mg/ kg are difficult to deliver via i.p. as described previously (33) and increased dosing error resulting in animal unscheduled death was also observed with intravenous administration in the previous study, 50 mg/kg was chosen as the maximum TiO 2 NPs dose and i.p. was selected for dosing route in this in vivo study. A single treatment of i.p. administered 100 mg/kg methyl methanesulphonate (MMS) was used as the positive control for the Comet assay. Four hours after treatment, liver and lung were collected from all the experimental groups. Fractions of the fresh tissues were immediately processed for the Comet assay and for tissue distribution analysis of Ti by ICP-MS. The other tissues were quickly frozen using liquid nitrogen and stored in a −80°C freezer until analysis.
Analysis of element titanium levels in liver and lung
Tissue samples were removed from −80°C and directly weighed into 20 ml Teflon digestion vessels. Samples were hydrolysed in 4 ml HNO 3 :HF (3:1) then processed using a MARSX-press digestion system (CEM, Matthews, NC, USA) operating at 100% power and 200°C with 20-min ramp and 40-min hold times. Following digestion, samples were diluted to 10 ml with 18 MΩ reagent water purified by a Millipore Direct Q-3 ultrapure system with BioPak cartridge (Billerica, MA, USA). Analysis was performed with a Thermo Scientific X-Series II ICP-MS using CCT-KED (collision cell technology-kinetic energy discrimination) capability (Waltham, MA, USA) with an inert PFA (perfluoroalkoxy) sample introduction kit. Calibration standards (0-1000 ppb Ti) were prepared in 30% HNO 3 , 10% HF to minimise matrix effects. Prior to analysis, standards and digested samples were diluted 1:5 in water and spiked with an internal standard (100 ppb scandium, Inorganic Ventures, Christiansburg, VA, USA). Data collected for stable titanium isotope Ti-49 (49Ti) was used for quantitation.
A second-source NIST traceable standard (SCP Science, Champlain, NY, USA) measuring within ±5% error verified instrument calibration. Spiked reagent samples measuring within ±10% error assured digestion and matrix recovery. The limit of detection (LOD) for this method is 0.32 ppb and was established as three times the average standard deviation of calibration blanks from six validation runs. The limit of quantification (LOQ) was 1.1 ppb, or 10 times the average standard deviation of six calibration blanks. The lower limit of quantification (LLOQ) and upper limit of quantification (ULOQ) were 5 and 1000 ppb, respectively, based on a 6-point calibration range of 5-1000 ppb. Calibration curves exhibited correlation coefficients of >0.995.
In vivo Comet assay
For tissue collection, a portion of the liver or lung was removed and washed in cold mincing buffer (Hanks Balanced Salt Solution, 20 mM EDTA and 10% dimethylsulfoxide) to remove as much blood as possible. The tissues were minced with a pair of fine scissors to release the cells. The cell suspension was then strained through a 40 µm cell strainer (Fisher Scientific, Pittsburgh, PA, USA) to remove lumps before the comet slide preparation.
The alkaline Comet assay was performed using established methods (38, 39) , with appropriate modifications. Briefly, 100 µl of the single cell suspension was mixed with 900 µl 1% low meltingpoint (LMP) agarose in PBS at 37°C, and 200 µl of this suspension were applied to microscope slides (Fisher Scientific, St. Louis, MO, USA) previously coated with 1% agarose. Slides were stored at 4°C for 30 min to solidify the LMP. Subsequently, the slides were put into lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, pH 10 by NaOH, with 10% dimethylsulfoxide (DMSO) and 1% Triton X-100 added just before use) for at least 1 h. After lysis, the slides were transferred into a chilled alkaline solution (300 mM NaOH, 1 mM EDTA, pH > 13) to allow the DNA to unwind. After unwinding for 40 min, electrophoresis was performed in the same alkaline solution at 4°C in the dark for 30 min at 25 V and 300 mA (0.7 V/cm). The slides then were washed with neutralising buffer (0.4 M TrisHCl, pH 7.5) three times for 5 min each; followed by fixing with ice cold ethanol (100%) and dried overnight. Prior to scoring, the slides were stained with a 1:10 000 dilution of SYBR I Gold (Invitrogen, Carlsbad, CA, USA) in Tris/Borate/EDTA buffer (TBE) and covered with coverslips. Two slides from each tissue/treatment/sampling time were scored; with at least 100 cells selected at random from each slide. Scoring was performed on a platform consisting of a Nikon 50i fluorescent microscope (Nikon, USA) and Comet IV digital imaging software (Perceptive Instruments, Wiltshire, UK). Percent (%) DNA in tail, defined as the fraction of DNA in the tail divided by the total amount of DNA associated with a cell multiplied by 100, was used as the parameter for DNA damage analysis. There were <1% 'hedgehogs' on the Comet slides, suggesting that a few cells had apoptosis and/or necrosis.
The human 8-hydroxyguanine DNA-glycosylase (hOGG1) and endonuclease III (EndoIII) -modified Comet assays were performed as described previously (40) . Both enzymes were obtained from New England Biolabs (Ipswich, MA, USA). Briefly, duplicated enzyme buffer reference slides, hOGG1-treated slides and EndoIII-treated slides were prepared in parallel with the standard Comet assay slides. After the lysis, slides were washed three times at 5 min each with enzyme buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/ml bovine serum albumin (BSA), pH 8.0 with KOH). After the last wash, the following solutions were applied to slides prepared from each enzymatic treatment group: 200 µl of enzyme buffer alone (enzyme buffer reference slides; two slides), 200 µl of enzyme buffer containing hOGG1 (1:1000, 1.6 U/ml; two slides), and 200 µl of enzyme buffer containing Endo III (1:1000, 10 U/ml; two slides). The enzyme-treated and enzyme buffer reference slides were kept in a slide box with high humidity and incubated at 37°C for 45 min. After the enzyme treatment, the slides were then immersed into chilled alkaline solution and processed as described for the standard assay.
The oxidative DNA damage calculation was based on the method described in a previous protocol (41) . The control gels (no enzyme treatment) provided an estimate of the background DNA strand breaks (SB). The enzyme-treated gels revealed a combination of strand breaks and oxidised bases (SB + OX); and assuming a linear dose response while using % DNA in tail, subtraction of SB from SB + OX generated a measure of oxidised pyrimidines/altered purines. The linear response was obtained by treating untreated samples with different concentrations (12.5, 25 and 50 µM) of hydrogen peroxide (H 2 O 2 ) (42).
RNA extraction and mouse whole genome microarray
Freshly collected tissues were quickly frozen using liquid nitrogen and stored in a −80°C freezer before RNA isolation. Total RNA from tissue samples was isolated using Trizol reagent following manufacturer's instruction (Life Technologies Corporation, Grand Island, NY, USA). The RNA concentration and quality were determined using a Nanodrop ND-1000 (NanoDrop Technologies, Wilmington, DE, USA) and an Agilent 2100 BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). The RNA was reverse-transcribed to cDNA labelled with fluorescent Cyanine 3 and 5 for the control the treatments, respectively. The labelled cDNA was used for hybridisation onto Whole Mouse Genome Microarray 4 × 44K slides (#G4122F, Agilent Technologies). The microarray chip contained approximately 41 534 60-mer oligonucleotide probes representing over 41 000 mouse genes and transcripts. The arrays were scanned on an Axon scanner GenePix 4000B (Molecular Devices, Sunnyvale, CA, USA) with 5 µm resolution and the images were analysed using GenePix Pro 6.1 (Molecular Devices).
Gene expression data analysis
Gene expression data from five samples each group were input into ArrayTrack software (NCTR, Jefferson, AR, USA) for the management, analysis, visualisation and interpretation of microarray data. Raw microarray intensity data were normalised using the median intensity method (43) . Identification of differentially expressed genes was based on permutation t-test. The principle component analysis (PCA) and hierarchical cluster analysis (HCA) were conducted using all of the normalised data. Gene expression with a fold change more than a 1.5-fold and a P value <0.01 was considered as a differentially expressed gene (DEG). The DEGs were further analysed using Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com) for their functions and pathways. Fisher's exact test was applied for assessing the functional changes. A pathway was considered significantly altered by the treatment when the difference between the treatment and control had a P value <0.05.
Quantitative polymerase chain reaction confirmation of gene expression
Four differentially expressed genes with the top changes in the liver and lung samples of animals treated with TiO 2 NPs and vehicle control were selected for TaqMan real-time quantitative polymerase chain reaction (PCR) to confirm the results from the microarray analysis. These selected genes were MT1H, MT1E, HP and ALDH1A1, and the reference gene, GAPDH was used for normalisation. The same total RNA used for microarray analysis was also used for the PCR confirmation with TaqMan assays kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Reverse transcriptase reactions were conducted according to the manufacture's instruction. The reactions were performed in an Applied Biosystems 9700 Thermocycler in a 96-well plate. Real-time PCR was conducted according to the protocol for standard TaqMan PCR on an Applied Biosystems 7500 Fast Real-Time PCR System. The threshold cycle (C t ) is defined as the fractional cycle number at which the fluorescence passes the fixed threshold 0.05. The C t data were determined using default threshold settings. The delta C t method was utilised for the qRT-PCR analysis to determine the relative expression of the genes (treatments vs. control).
Statistical analysis
For the Comet assay, statistical significance for %DNA tail between treatment group and concurrent control group was determined by one-way ANOVA followed with the Shapiro-Wilk test. For measurement of titanium element, statistical significance between treatment group and concurrent control group was determined by one-way ANOVA followed with the Holm-Sidak method. P < 0.05 was used to indicate significant differences. Both analyses were conducted using SigmaPlot software (Systat Software, Inc.).
Results
TiO 2 NP accumulation in mouse liver and lung
Element Ti was measured at 411.94 ± 297.58 μg/g (wet weight) in liver and 682.50 ± 142.15 μg/g (wet weight) in lung tissues 4 h following treatment of mice treated with a single i.p. dose of 50 mg/kg TiO 2 NPs (Table 1 ). In contrast, the average elemental Ti levels were measured at 1 μg/g tissue in both live and lung tissues of vehicle control mice. These data indicated significant TiO 2 NP accumulation in liver and lung tissues 4 h post-treatment.
DNA damage was induced by TiO 2 NPs in mouse liver and lung
The standard Comet assay indicated the TiO 2 NP treatment significantly increased DNA damage in liver while the treatment did not induce significant DNA breaks in lung tissue ( Figure 1A ). The enzyme-modified Comet assay indicated the TiO 2 NP treatment significantly increased oxidative DNA damage in both liver and lung following addition of both hOGG1 ( Figure 1B ) and ENDOIII ( Figure 1C ).
Global gene expression was altered by TiO 2 NP treatment in mouse liver and lung
To explore the impact of TiO 2 NP exposure on genome-wide gene expression in liver and lung, PCA was performed to visualise the profile of all expressed genes. As shown in Figure 2A and B, the liver and lung tissues from the mice treated with TiO 2 NPs grouped separately from the vehicle control samples, indicating a difference in gene expression patterns between the control and TiO 2 NP-treated groups. Similar groupings are also shown in the HCA with the exception of one TiO 2 NP treatment sample ( Figure 2C and D) .
Genes whose expression levels were significantly changed by TiO 2 NPs DEGs were selected based on a criterion of fold change >1.5 and P < 0.01. According to this criterion, 1291 DEGs in liver and 1063 DEGs in lung tissue from TiO 2 NP treated mice were identified (Supplementary Tables 1 and 2 ). The DEG data presented as Volcano plots are shown in Figure 3 . Among those DEGs, 402 were up-regulated and 889 were down-regulated in liver and 965 were up-regulated and 98 down-regulated in lung. The 10 genes with the highest up-regulated and down-regulated levels in liver and lung tissues are listed in Table 2 . Most of these DEGs in liver are involved in metabolic processes while most of the DEGs in lung are in response to oxidative stress, inflammatory response and apoptosis.
Several DEGs in liver and lung were analysed using TaqMan RT-PCR and the results confirmed the results from the microarray analysis (Table 3) . MT1H and MT1E, the top two up-regulated genes in liver tissue, increased 12.8-and 8.1-fold, respectively, and were reasonably similar to the expression levels observed in the microarray analysis. Similar trends in gene expression levels between the microarray analysis and the RT-PCR experiment for the top two up-regulated DEGs, HP and ALDHIA1, were also observed in the lung tissue.
Functional analysis of the differentially expressed genes induced by TiO 2 NP exposure
The DEGs in mouse liver and lung were imported into IPA software for categorisation by their key functions and pathways. There were 1035 genes in liver and 981 genes in lung mapped into the IPA database for the functional and pathway analysis. The analysis revealed a number of networks significantly altered by the treatment (Supplementary Tables 3 and 4 ). The top five most significantly altered networks in liver and lung tissues are listed in Table 4 . In addition to network analysis, IPA also generated results from analysis of canonical and toxicological pathways associated with the treatment. LXR/RXR activation (P = 1.74E-04), phosphatidylethanolamine biosynthesis II (P = 1.92E-04), PXR/RXR activation (P = 1.92E-03), phosphatidylcholine biosynthesis I (P = 2.3E-03) and gluconeogenesis I (P = 3.47E-03) were the top five canonical pathways in liver ( Figure 4A ) whereas EIF2 signalling (P = 6.1E-04), mitochondrial dysfunction (P = 1.47E-03), regulation of eIF4 and p70S6K signalling (P = 3.04E-03), phosphatidylglycerol biosynthesis II (non-plastidic) (P = 3.5E-03), and clathrin-mediated endocytosis signalling (P = 4.2E-03) are the top five canonical pathways in lung ( Figure 4B) .
In order to identify the key functions and pathways related to potential in vivo toxicity of TiO 2 NPs, toxicity pathways were also analysed using IPA. As shown in Figure 4C , LXR/RXR activation (P = 6.57E-05), mechanism of gene regulation by peroxisome proliferators via PPARα (P = 6.38E-04), liver proliferation (P = 8.77E-04), renal safety biomarker panel (P = 1.36E-03) and LPS/IL-1 mediated inhibition of RXR function (P = 1.77E-03) were the top five toxicity pathways observed in the liver. As for TiO 2 NP exposed lung tissues (Figure 4D ), the top pathways were mitochondrial dysfunction (P = 1.69E-03), renal inorganic phosphate homeostasis (P = 2.28E-02), oxidative stress (P = 2.93E-02), renal glomerulus panel (P = 3.08E-02) and NRF2-mediated oxidative stress response (P = 3.11E-02). All the data are expressed as mean ± SD. ***P < 0.001, there was a significantly difference between the treatment and the vehicle control in both lung and liver tissues.
Discussion
Tissue distribution of TiO 2 NPs
Increased levels of titanium were observed in the mouse liver and lung 4 h after the last i.p. treatment of 50 mg/kg TiO 2 NPs (Table 1) . The Ti concentrations in liver and lung of the treatment groups were 490-and 620-fold over their concurrent controls, which was much higher than the Ti levels observed in bone marrow in our previous study (33) . In that study, mice treated with 50 mg/kg of the same NPs daily for three consecutive days via intravenous administration resulted in a 12-fold increase in Ti accumulation in bone marrow. These increased levels of TiO 2 NPs in different tissues were largely consistent with the findings in a previous study via oral route in mice (44) , where the Ti levels examined after 2 weeks following a single dose of 5 g/kg BW in the liver tissue as 3970.4 ± 1670.1 ng/g in the 80 nm group and 106.3 ± 7.8 ng/g in the 25 nm group. In the kidneys, the Ti concentrations in the 80 and 25 nm TiO 2 group are significantly higher than those in the control and fine particle groups (P < 0.05). In mice and rats via intravenous injections of 1 mg/ml TiO 2 NPs, the results indicated that the TiO 2 NPs mainly accumulated in liver and spleen and retained with a significant amount of TiO2 NPs (about 5% injected dose per gram tissue) 30 days after injection (41) . Significantly higher retention TiO 2 NPs were observed in liver and spleen in rats 30 days after i.v. administration of TiO 2 NPs (1 ml/kg BW), while they were 220 000 ± 34 000 ng/organ and 4300 ± 770 ng/organ, respectively. By contrast, the TiO 2 accumulation in the lung, kidney, heart and blood decreased over time, and the decrease was statistically significant (45) . Another study in rat found the TiO 2 levels were highest in the liver, followed in decreasing order by the levels in the spleen, lung and kidney, and highest on Day 1 in all organs. And TiO 2 levels were retained in the liver for 28 days (46) .
It has been suggested that there are four key mechanisms underlying NP uptake by cells and tissues, including clathrin-mediated endocytosis, caveolin-dependent endocytosis, micropinocytosis and phagocytosis (47) (48) (49) . In the present gene expression study, IPA canonical pathways analysis showed that clathrin-mediated endocytosis Figure 1 . DNA damage and oxidative DNA adducts measured with the Comet assays in liver and lung tissues of the mice treated with 50 mg/kg TiO 2 NPs. DNA strand breaks were measured in the standard Comet assay for liver and lung tissues. MMS at 100 mg/mg was used as the positive control (A). Oxidative DNA adducts were examined using endonucleases enzyme-modified Comet assay with addition of hOGG1 (B) or endo III enzymes (C). The value for % DNA in tail in (B) and (C) represent the net increase of DNA strand breaks resulted from oxidised DNA adducts. The error bars represent the standard errors of the mean. *, ** and ***indicates P < 0.05, P < 0.01 and P < 0.001, respectively. Global gene expression profiles in liver and lung of mice treated with 50 mg/kg TiO 2 NPs. The principal component analysis using the first three principal components (PC1, PC2 and PC3) revealed a distinct separation of samples from the treatment and controls in liver (A) and lung (B). Hierarchical cluster analysis also grouped samples according to the treatment and control in liver (C) and lung (D). The hierarchical cluster analysis was performed using Ward's method and the colour indicates the magnitude of the differences in the gene expression. (Table 5) , suggesting a possible mechanism for mouse lung internalisation of TiO 2 NPs. Although it was not noted in the mouse liver in the present study, the clathrin-mediated endocytosis signalling pathway has been recognised in HepG2 cells (50) . Studies using human lung epithelial cells and prostate cancer PC-3M cells also have demonstrated that the clathrin-mediated pathway is a key mechanism for endocytosis of TiO 2 NPs (51,52). When an inhibitor (chloropromazine) for clathrin-mediated endocytosis was used, a large decrease in Ti accumulation in the cells was observed (53) .
Genotoxicity of TiO 2 NPs in mouse
DNA strand breakage was measured with the standard Comet assay; and oxidative DNA adducts were determined using an endonuclease enzyme modified Comet assay. Although the treatment increased DNA strand breaks marginally, about a 10-20% increase over the controls, in both liver and lung, only the induction of DNA strand breaks in the liver was statistically significant. However, the induction of DNA damage observed in the enzyme-modified assay was much higher, a 4-to 5-fold induction over the controls in both the hOGG1-and EndoIII-modified Comet assays in mouse liver and lung. Induction of DNA breaks following the addition of hOGG1 and EndoIII suggests that the DNA damage resulting from the TiO 2 NP treatment was mainly due to oxidised nucleotides. A previous study (54) analysed the interactions between anatase TiO 2 NPs and DNA extracted from the livers of intraperitoneally exposed mice found that anatase TiO 2 NPs could insert into DNA base pairs, bind to DNA nucleotides, and alter the secondary structure of DNA, causing DNA cleavage and hepatocyte apoptosis. This may explain the positive results observed with the standard Comet assay in mouse liver. It is well known that NPs induce oxidative DNA damage in cells. Therefore, it was not surprising that the enzyme-modified Comet assay identified high levels of oxidised nucleotides induced by the TiO 2 NPs treatment in both the liver and lung tissues.
In our previous study, mice were treated intravenously for three consecutive days with 50 mg/kg TiO 2 NPs and the mouse blood was used for the micronucleus assay and Pig-a mutation assay. The treatment induced neither micronuclei nor mutations in the Pig-a gene, although the NPs reached the bone marrow and induced blood cell cytotoxicity. This tissuespecific response to the genotoxicity of TiO 2 NPs might be due to differential TiO 2 NPs distribution in the liver, lung blood and bone marrow tissues as we discussed above, and/or due to the different genotoxicity endpoints the assays measured. Other researchers have also found that TiO 2 NP can induce liver damage in mice and rats, indicating liver and lung are the target tissues while bone marrow is not (31, (55) (56) (57) .
Gene expression profiling revealed the early responses to TiO 2 NP toxicities
The cellular and molecular mechanisms underlying TiO 2 NPs-induced adverse health effects in lung and liver at early exposure stages are largely unknown. Gene expression analysis can be used to quickly screen for early biomarkers that are predictors for the potential pulmonary toxicity and liver injury induced by TiO 2 NPs and to explore possible mechanisms underlying the TiO 2 NPs-induced toxicities. The gene expression profiles in this study revealed that the TiO 2 NPs treatment resulted in global gene expression alterations in both murine liver and lung tissues. The PCA and HCA demonstrate that the tissues from TiO 2 NPs-treated mice had different gene expression patterns from the control samples in both liver and lung, suggesting that the NP exposure can be identified based on gene expression profiles in different tissues. By analysing these DEGs using IPA functional and pathway analysis, we found that the DEGs were primarily involved in the oxidative stress response, inflammatory response and apoptosis in lung; and the DEGs were primarily related to metabolic processes in liver. One of the early responses for lung gene expression following the TiO 2 NPs exposure was oxidative stress, which was further confirmed by our results from the enzyme-modified Comet assay ( Figure 1B and C) . IPA analysis of toxicity pathways revealed that oxidative stress and the NRF2-mediated oxidative stress response were two of the most significantly regulated pathways in response to the NP treatment. Oxidative stress can enhance ROS level in cells, leading to formation of oxidised DNA adducts (58) (59) (60) . It has been reported that TiO 2 NPs can generate high intracellular ROS levels, formation of 8-OHdG in human lung cells (14) , and generation of hydrogen peroxide and nitric oxide, leading to lipid peroxidation and oxidative DNA adducts in human bronchial epithelial cells (17) . With elevated ROS levels, cells initiate a protective response by stabilising and activating transcription factor NRF2 (58) , which can induce the transcription of >200 downstream target genes including antioxidants and detoxification enzymes (61) . Also, gene expression patterns associated with mitochondrial dysfunction was identified by the IPA canonical analysis. Several other studies also reported TiO 2 NPs induced mitochondrial dysfunction (56, 57, 62) . Most of the genes involved in the mitochondrial dysfunction pathway (Table 4) are involved in the mitochondrial electron transport chain (ETC). Since the mitochondrial ETC is a major source for endogenous generation of ROS (56) , this finding suggests that ROS generation through respiratory chain impairment might play an important role in TiO 2 NP toxicities, providing a possible mechanism for TiO 2 NP-induced mutagenesis and carcinogenesis.
Oxidative stress increased by NPs, in turn, can induce cytokine production (63) and inflammation (64, 65) . The pulmonary inflammation response has been identified due to TiO 2 NPs exposure in both in vitro (66) and in vivo (67) systems, as well as in this study. The haptoglobin gene had the highest up-regulated expression in lung in the present study. Haptoglobin is one of the typical acute phase proteins responding to infection and inflammation (68) . Increased levels of haptoglobin in plasma have been observed following exposure to single-walled carbon nanotubes, SiO 2 NPs (69) and silica (70) . It has been suggested that haptoglobin can serve as a biomarker for predicting exposure of nanomaterials (70) .
The gene expression analysis also indicated that apoptosis was activated by TiO 2 NP exposure in mouse lung. The anti-apoptotic gene BCL2L1 was be up-regulated to respond to TiO 2 NP-induced apoptosis. In addition, EIF2 signalling and the eIF4 regulated pathways that are associated with the induction of apoptotic cell death (71, 72) were activated by TiO 2 NP exposure in lung. Several DEGs in the EIF2 signalling pathway were up-regulated, such as EIF2AK1 (Table 4) . Upon EIF2AK1 activation, a translational inhibitory response will remediate cellular damage, or alternatively induce apoptosis (73, 74) The EIF4E signalling pathway mediates apoptosis via control of the initiation of protein synthesis by eukaryotic initiation factor eIF4E and the eIF4E binding proteins (4E-BPs). Changes in the phosphorylation of the 4E-BPs and in the extent of their association with eIF4E occur at an early stage in cells responding to apoptotic inducers (75) .
In the liver, MT1H and MT1E, genes encoding metallothioneins, ranked as the two highest up-regulated DGEs following TiO 2 NP exposure. Metallothioneins are antioxidant and metal detoxifying enzymes, which are up-regulated during high levels of oxidative stress and heavy metals in cells. Similar results involving up-regulation of metallothioneins have been reported in other studies with TiO 2 NPs (31), silver NPs (76,77) and C 60 fullerene NPs (78) . A number of DEGs were related to metabolic processes in liver, such as ALAS1 involved in cellular lipid metabolism, G6PC involved in carbohydrate metabolism and cholesterol homeostasis and UPP2 involved in nucleoside metabolism. The top five canonical pathways in the liver were also related to metabolism (Table 5 ). These pathways are involved in lipid metabolism and glucose metabolism. Liver X receptors (LXRs) form functional heterodimers with the retinoid X receptors (RXRs) to regulate cholesterol, lipid and glucose metabolism (79) . Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are two important phospholipids in mammalian tissues (80) . The biosynthesis of phosphatidylcholine is intricately associated with plasma lipoprotein homeostasis (81) . Inhibition of PC synthesis could lead to liver failure (82) . And PE plays significant roles in cellular processes such as membrane fusion (83) , cell cycle (84), autophagy (85) and apoptosis (86) . PXR forms a heterodimer with the RXR to bind to DNA response elements in regulatory regions of target genes. PXR-RXR heterodimers can bind multiple elements in CYP3A promoters in vitro and activate the CYP3A promoter in cells (87, 88) . In addition, TiO 2 NPs elicited up-regulation of CYP2A13/ CYP2A6, CYP7A1 and down-regulation of other metabolising enzymes such as SULT2A1 and UGT1A9, which are part of the PXR/RXR activation pathway (Table 4 ).
Conclusions
Following three daily i.p. injections of 50 mg/kg 10 nm anatase TiO 2 NPs, the NPs were heavily accumulated in liver and lung tissues 4 h after the treatment. Genotoxicity and gene expression analyses demonstrated that the NPs impaired DNA and interrupted metabolic homeostasis in the liver tissue while inducing oxidative stress, inflammatory responses and apoptosis in lung tissue. DNA damage mainly resulted from oxidised nucleotides due to TiO 2 NP-induced oxidative stress. In the liver, oxidative stress was related to the NP's interrupting lipid and glucose metabolism, as well as dysregulation of xenobiotic metabolism. Oxidative stress trigged in lung tissue might have resulted from impairment of the mitochondrial electron respiratory chain. In addition, TiO 2 NP-induced oxidative stress, inflammation and apoptosis could be related to the lung-specific carcinogenesis of the NPs. These findings have broad implications when evaluating the safety of TiO 2 NPs used in numerous consumer products.
Supplementary data
Supplementary Table 1-4 are available at Mutagenesis Online.
